GLS and cancer: Muir et al, demonstrated that cystine levels in extrinsic media and xCT/SLC7A11 (cystine transporter) expression are critical determinants of glutamine anaplerosis and glutaminase dependence in cancer cells and may explain the lack of efficacy of GLS1 targeting drugs in MM (60).